Mental Health News

NEW YORK--(BUSINESS WIRE)--Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapies targeting the underlying causes of psychiatric and neurological disorders, today issued the following statement supporting the newly signed White House Executive Order aimed at accelerating research, development, and responsible access to innovative treatments for serious mental illness, including emerging psychedelic medi...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, welcomes the White House Executive Order on accelerating medical treatments for serious mental illness. “We commend the Administration’s Executive Order on psychedelic treatment which recognizes the profound urgency of the mental health crisis facing millions of Americans and the potential impact FDA-approved psychedelics could h...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing novel neuroplastogenic small-molecule therapeutics to address psychiatric and neurological disorders, today announced that it has entered into definitive agreements for the purchase and sale of 2,222,223 shares of its common stock (or pre-funded warrants in lieu thereof), Series I warrants to purchase up to an aggregate of 2,222,223 shares of common stock a...

DEDHAM, Mass.--(BUSINESS WIRE)--Insights from Men in Fishing, Mining, and Construction Industries Point to Suicide Prevention and Mental Health Efforts that Can Save Lives...

DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced plans to present new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of Neurology (AAN) 2026 Annual Meeting, taking place April 18-22, 2026 in Chicago. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment of NT1, narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH). Vibrance-1,...

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2026 financial results on Wednesday, May 6, 2026, after the close of the U.S. financial markets. Acadia’s management team will also host a conference call and webcast on May 6, 2026, at 4:30 p.m. Eastern Time. The conference call will be available on Acadia’s website, acadia.com under the investors section and will be archived there until August 15, 2026. The conference call...

MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Children’s Minnesota is excited to announce the 34th annual Star Gala raised a record-breaking $3.7 million to benefit the nonprofit pediatric health system’s mental health program. Star Gala is regarded as one of the biggest nights of the year for the Twin Cities philanthropic community. This year’s event supported The Kid Experts® at Children’s Minnesota who support children and families across the full continuum of mental health care, from outp...

DALLAS--(BUSINESS WIRE)--Caregiving shapes how work gets done, often in ways that remain invisible. The 2026 Future of Benefits Report, released today from CareBenefits by Care.com, reveals a gap between identity and reality: only 37% of employees identify as caregivers, even as many are already providing care and others expect to in the future. There is also a clear perception gap when it comes to employee stress. While 81% of employees report moderate to high stress overall, employers estimat...

MINNEAPOLIS--(BUSINESS WIRE)--Voya Financial (NYSE: VOYA) today announced a new collaboration with TELUS Health to integrate their Employee Assistance Program (EAP) services in conjunction with Group Annual Term Life Insurance offered by Voya. The robust array of EAP services is available to help individuals improve emotional well-being and address personal, family and life challenges while also supporting productivity and resilience in the workplace. Through this collaboration, Voya will offer...